Duration and Frequency of Lapses in Care Among Patients with Proliferative Diabetic Retinopathy.
作者信息
Applebaum Serina, Fu Julia, Nwanyanwu Kristen
机构信息
Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT, USA.
出版信息
Ophthalmic Epidemiol. 2025 Mar 25:1-4. doi: 10.1080/09286586.2025.2463067.
Abstract
摘要
相似文献
1
Duration and Frequency of Lapses in Care Among Patients with Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变患者护理中断的持续时间和频率
Ophthalmic Epidemiol. 2025 Mar 25:1-4. doi: 10.1080/09286586.2025.2463067.
2
Health Disparities in Lapses in Diabetic Retinopathy Care.糖尿病视网膜病变护理失误中的健康差异。
Ophthalmol Sci. 2023 Mar 4;3(3):100295. doi: 10.1016/j.xops.2023.100295. eCollection 2023 Sep.
3
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较：系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
4
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较：一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
5
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制。
Cochrane Database Syst Rev. 2023 Mar 28;3(3):CD006127. doi: 10.1002/14651858.CD006127.pub3.
6
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较：一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
7
Use of automated quantitative pupillometric evaluation for monitoring the severity of diabetic retinopathy.使用自动化定量瞳孔计评估监测糖尿病视网膜病变的严重程度。
Arq Bras Oftalmol. 2021 Jan-Feb;84(1):37-44. doi: 10.5935/0004-2749.20210007.
8
Laser photocoagulation for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的激光光凝治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD011234. doi: 10.1002/14651858.CD011234.pub2.
9
Familial clustering of diabetic kidney disease and retinopathy in offspring of parents with type 1 diabetes: a population-based study.1型糖尿病患者后代中糖尿病肾病和视网膜病变的家族聚集性：一项基于人群的研究。
EClinicalMedicine. 2025 May 6;83:103232. doi: 10.1016/j.eclinm.2025.103232. eCollection 2025 May.
10
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制
Cochrane Database Syst Rev. 2015 Jan 31;1:CD006127. doi: 10.1002/14651858.CD006127.pub2.
本文引用的文献
1
Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic Retinopathy.治疗类型和随访丢失与增生性糖尿病视网膜病变牵拉性视网膜脱离的相关性。
JAMA Ophthalmol. 2023 Jan 1;141(1):40-46. doi: 10.1001/jamaophthalmol.2022.4942.
2
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial.接受雷珠单抗治疗增生性糖尿病视网膜病变患者的护理失误：一项随机临床试验的事后分析。
JAMA Ophthalmol. 2021 Dec 1;139(12):1266-1273. doi: 10.1001/jamaophthalmol.2021.4103.
3
Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes.有新诊断 2 型糖尿病的参保患者的眼科保健和糖尿病眼病发生率。
Ophthalmol Retina. 2021 Feb;5(2):160-168. doi: 10.1016/j.oret.2020.07.004. Epub 2020 Jul 9.
4
Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy.增殖型糖尿病视网膜病变患者失访的预测因素。
Am J Ophthalmol. 2020 Aug;216:18-27. doi: 10.1016/j.ajo.2020.03.023. Epub 2020 Mar 31.
5
Loss to Follow-Up Among Patients With Proliferative Diabetic Retinopathy in Clinical Practice.增生型糖尿病视网膜病变患者临床随访丢失情况。
Am J Ophthalmol. 2020 Jul;215:66-71. doi: 10.1016/j.ajo.2020.03.011. Epub 2020 Mar 21.
6
Barriers to and Facilitators of Diabetic Retinopathy Screening Utilization in a High-Risk Population.高危人群糖尿病视网膜病变筛查利用的障碍和促进因素。
J Racial Ethn Health Disparities. 2019 Dec;6(6):1244-1249. doi: 10.1007/s40615-019-00627-3. Epub 2019 Aug 28.
7
Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.接受全视网膜光凝与玻璃体内抗血管内皮生长因子治疗后随访丢失的增生性糖尿病视网膜病变眼的结局。
Ophthalmology. 2019 Mar;126(3):407-413. doi: 10.1016/j.ophtha.2018.07.027. Epub 2018 Aug 2.
8
Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.增生性糖尿病视网膜病变患者行全视网膜光凝或玻璃体内抗 VEGF 注射后的失访分析。
Ophthalmology. 2018 Sep;125(9):1386-1392. doi: 10.1016/j.ophtha.2018.02.034. Epub 2018 Mar 29.
9
Vision health disparities in the United States by race/ethnicity, education, and economic status: findings from two nationally representative surveys.美国种族/民族、教育和经济地位方面的视力健康差距：两项全国代表性调查的结果。
Am J Ophthalmol. 2012 Dec;154(6 Suppl):S53-62.e1. doi: 10.1016/j.ajo.2011.08.045.
10
Diabetic retinopathy.糖尿病视网膜病变
N Engl J Med. 2012 Mar 29;366(13):1227-39. doi: 10.1056/NEJMra1005073.
Zotero 插件